Search Results

Filter
  • 1-10 of  1,049 results for ""Pseudomonas Infections""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Surface modified niosomal quercetin with cationic lipid: an appropriate drug delivery system against Pseudomonas aeruginosa Infections.

  • Authors : Hemmati J; Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.; Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.

Subjects: Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects ; Liposomes*/Liposomes*/Liposomes*/chemistry ; Quercetin*/Quercetin*/Quercetin*/pharmacology

  • Source: Scientific reports [Sci Rep] 2024 Jun 11; Vol. 14 (1), pp. 13362. Date of Electronic Publication: 2024 Jun 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Metabolic Modulation-Mediated Antibiotic and Immune Activation for Treatment of Chronic Lung Infections.

  • Authors : Xiu W; State Key Laboratory of Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing210023, China.; Dong H

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/chemistry ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects

  • Source: ACS nano [ACS Nano] 2024 Jun 11; Vol. 18 (23), pp. 15204-15217. Date of Electronic Publication: 2024 May 27.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa.

  • Authors : Ferretti C; Department of Biology, University of Pisa, Pisa, Italy.; Poma NV

Subjects: Biofilms*/Biofilms*/Biofilms*/drug effects ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects ; Imipenem*/Imipenem*/Imipenem*/pharmacology

  • Source: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2024 Jun; Vol. 37, pp. 53-61. Date of Electronic Publication: 2024 Feb 06.Publisher: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Country of Publication: Netherlands NLM ID:

Record details

×
Academic Journal

Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.

  • Authors : Breen SKJ; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Harper M

Subjects: Tobramycin*/Tobramycin*/Tobramycin*/administration & dosage ; Tobramycin*/Tobramycin*/Tobramycin*/pharmacology ; Aztreonam*/Aztreonam*/Aztreonam*/pharmacology

  • Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Jun; Vol. 63 (6), pp. 107161. Date of Electronic Publication: 2024 Mar 30.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Pseudomonas aeruginosa senses and responds to epithelial potassium flux via Kdp operon to promote biofilm.

  • Authors : Rapsinski GJ; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United State of America.; Division of Infectious Disease, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

Subjects: Biofilms*/Biofilms*/Biofilms*/growth & development ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/genetics ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/metabolism

  • Source: PLoS pathogens [PLoS Pathog] 2024 May 31; Vol. 20 (5), pp. e1011453. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

High-Intensity Blue Light (450-460 nm) Phototherapy for Pseudomonas aeruginosa -Infected Wounds.

  • Authors : Zoric A; Department of Plastic, Reconstructive and Aesthetic Surgery, RKH Hospital Bietigheim-Vaihingen, Bietigheim-Bissingen, Germany.; Bagheri M

Subjects: Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/radiation effects ; Biofilms*/Biofilms*/Biofilms*/radiation effects ; Pseudomonas Infections*/Pseudomonas Infections*/Pseudomonas Infections*/therapy

  • Source: Photobiomodulation, photomedicine, and laser surgery [Photobiomodul Photomed Laser Surg] 2024 May; Vol. 42 (5), pp. 356-365.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101734781 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Increased tolerance to commonly used antibiotics in a Pseudomonas aeruginosa ex vivo porcine keratitis model.

  • Authors : Okurowska K; Department of Chemical and Biological Engineering, University of Sheffield, Sheffield S10 2TN, UK.; National Institute for Health and Care Research, University of Leeds, Leeds LS2 9JT, UK.

Subjects: Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/growth & development ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology

  • Source: Microbiology (Reading, England) [Microbiology (Reading)] 2024 May; Vol. 170 (5).Publisher: Microbiology Society Country of Publication: England NLM ID: 9430468 Publication Model: Print Cited Medium: Internet ISSN: 1465-2080

Record details

×
Academic Journal

Cell-free supernatants from Lactobacillus strains exert antibacterial, antibiofilm, and antivirulence activity against Pseudomonas aeruginosa from cystic fibrosis patients.

  • Authors : Pompilio A; Department of Medical, Oral, and Biotechnological Sciences, G. d'Annunzio University of Chieti-Pescara, Via dei Vestini, 31, 66100 Chieti, Italy; Center for Advanced Studies and Technology, G. d'Annunzio University of Chieti-Pescara, Via L. Polacchi 11, 66100 Chieti, Italy.

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/microbiology ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/complications ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects

  • Source: Microbes and infection [Microbes Infect] 2024 May-Jun; Vol. 26 (4), pp. 105301. Date of Electronic Publication: 2024 Jan 17.Publisher: Elsevier Country of Publication: France NLM ID: 100883508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-714X

Record details

×
Academic Journal

Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.

  • Authors : Wang J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease Guangzhou Institute of Respiratory Health The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Road, Guangzhou 510120, Guangdong, China.; Guo Y

Subjects: Ciprofloxacin*/Ciprofloxacin*/Ciprofloxacin*/administration & dosage ; Ciprofloxacin*/Ciprofloxacin*/Ciprofloxacin*/pharmacology ; Ciprofloxacin*/Ciprofloxacin*/Ciprofloxacin*/chemistry

  • Source: International journal of pharmaceutics [Int J Pharm] 2024 Jun 10; Vol. 658, pp. 124208. Date of Electronic Publication: 2024 May 07.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Enzyme-Linked Lipid Nanocarriers for Coping Pseudomonal Pulmonary Infection. Would Nanocarriers Complement Biofilm Disruption or Pave Its Road?

  • Authors : Nafee N; Department of Pharmaceutics, College of Pharmacy, Kuwait University, Safat, 13110, Kuwait.; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt.

Subjects: Biofilms*/Biofilms*/Biofilms*/drug effects ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/physiology

  • Source: International journal of nanomedicine [Int J Nanomedicine] 2024 Apr 29; Vol. 19, pp. 3861-3890. Date of Electronic Publication: 2024 Apr 29 (Print Publication: 2024).Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  1,049 results for ""Pseudomonas Infections""